Delivery Order SPE2DB25D9320-SPE2DB25FWFCQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's existing $499.999 billion Indefinite Delivery Contract with DLA through the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the provision of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, was issued without a set-aside designation. Performance will take place at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contract represents a discrete fulfillment under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- The Defense Logistics Agency awarded a $15,031.17 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 21, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois, and represents a continuation of the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on August 5, 2025, for the supply of YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a straightforward pharmaceutical procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- This delivery order, valued at $1,113.42, represents a firm fixed-price award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract carries an ultimate completion date of September 23, 2025, and was awarded on September 2, 2025, with no set-aside designation applied. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 20, 2025. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will supply the yellow fever vaccine vials to support federal healthcare needs....
- The Defense Logistics Agency issued a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 16, 2025, and was awarded on August 25, 2025, without any set-aside designation. This delivery order represents an individual procurement action issued under DMS...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFCQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract employs firm fixed-price pricing and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This delivery order falls within the company's established portfolio of providing comprehensive pharmaceutical products and medical supplies to federal healthcare systems. YF-VAX is a yellow fever vaccine distributed in single-dose vial format, reflecting the Defense Logistics Agency's procurement of vaccines and biological products to support medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent success in federal pharmaceutical procurement, leveraging its woman-owned small business status to compete effectively for delivery orders covering an extensive range of medications, biologics, and medical consumables. The company's positioning as a crucial supplier in the federal pharmaceutical supply chain enables direct distribution of prescription drugs and specialty pharmaceutical products to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/2/25 |